Home Halogens 1-[2-(4-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate

1-[2-(4-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate

CAS No.:
82382-23-8
Catalog Number:
AG005C2L
Molecular Formula:
C18H16Cl3N3O3S
Molecular Weight:
460.7619
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
>98%(HPLC)powder
In Stock USA
United States
$60
- +
25mg
>98%(HPLC)powder
In Stock USA
United States
$86
- +
100mg
>98%(HPLC)powder
In Stock USA
United States
$155
- +
Product Description
Catalog Number:
AG005C2L
Chemical Name:
1-[2-(4-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate
CAS Number:
82382-23-8
Molecular Formula:
C18H16Cl3N3O3S
Molecular Weight:
460.7619
MDL Number:
MFCD00058163
IUPAC Name:
1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid
InChI:
InChI=1S/C18H15Cl3N2S.HNO3/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21;2-1(3)4/h1-9,12,18H,10-11H2;(H,2,3,4)
InChI Key:
CRKGMGQUHDNAPB-UHFFFAOYSA-N
SMILES:
Clc1ccc(cc1)CSC(c1ccc(cc1Cl)Cl)Cn1cncc1.[O-][N+](=O)O
NSC Number:
757849
Properties
Complexity:
404  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
458.998g/mol
Formal Charge:
0
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
460.754g/mol
Monoisotopic Mass:
458.998g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
109A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
[Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains]. Mikrobiyoloji bulteni 20110101
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Enantioselective addition of thioacetic acid to nitroalkenes via N-sulfinyl urea organocatalysis. Journal of the American Chemical Society 20090701
Enantioselective separation of azole compounds by EKC. Reversal of migration order of enantiomers with CD concentration. Electrophoresis 20070801
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Molecular properties of econazole and sulconazole relevant to bioavailability. Acta poloniae pharmaceutica 20060101
Athlete's foot. Clinical evidence 20051201
Effect of (+) or (-) camphorsulfonic acid additives to the mobile phase on enantioseparations of some basic drugs on a Chiralcel OD column. Journal of chromatography. A 20050812
EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme. Biochemistry 20041123
Rapid method development for chiral separation in drug discovery using multi-column parallel screening and circular dichroism signal pooling. Journal of chromatography. A 20040917
Chiral separation by capillary electrophoresis using polysaccharides. Methods in molecular biology (Clifton, N.J.) 20040101
Topical antifungal treatment cures exit-site fungal infection. American journal of kidney diseases : the official journal of the National Kidney Foundation 20021001
Comparative study of the enantiomeric resolution of chiral antifungal drugs econazole, miconazole and sulconazole by HPLC on various cellulose chiral columns in normal phase mode. Journal of pharmaceutical and biomedical analysis 20020115
Comparison of the chiral resolution of econazole, miconazole, and sulconazole by HPLC using normal-phase amylose CSPs. Fresenius' journal of analytical chemistry 20010801
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp. Mycopathologia 19920401
Percutaneous absorption of sulconazole nitrate in humans. Journal of pharmaceutical sciences 19880601
Properties